Rankings
▼
Calendar
BSX Q4 2020 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena
BSX
Boston Scientific Corporation
$105B
Q4 2020 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$2.7B
-6.8% YoY
Gross Profit
$1.5B
55.4% margin
Operating Income
$174M
6.4% margin
Net Income
$152M
5.6% margin
EPS (Diluted)
$0.10
QoQ Revenue Growth
+1.8%
Cash Flow
Operating Cash Flow
$673M
Free Cash Flow
$514M
Stock-Based Comp.
$42M
Balance Sheet
Total Assets
$30.8B
Total Liabilities
$15.5B
Stockholders' Equity
$15.3B
Cash & Equivalents
$1.7B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.7B
$2.9B
-6.8%
Gross Profit
$1.5B
$1.8B
-17.8%
Operating Income
$174M
$409M
-57.5%
Net Income
$152M
$4.0B
-96.2%
Revenue Segments
Cardiovascular
$1.0B
53%
MedSurg
$891M
47%
Geographic Segments
UNITED STATES
$1.5B
57%
Non-US
$1.2B
43%
← FY 2020
All Quarters
Q1 2021 →